Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Keywords
DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.
Brief summary
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Asia. Further perceptions and practices of physicians and subjects about diabetes management in Asia will be evaluated.
Interventions
OTHERNo treatment given
No treatment is given
Sponsors
Novo Nordisk A/S
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Diabetic patients registered in the particular centre for more than 12 months. * Patients should have visited the centre at least once in the last 3-6 months before the initial study visit. * Patients willing to sign informed consent form.
Exclusion criteria
* Repetition of any patient as patients should not be included twice for any reason. * Unwilling to participate or unable to comply with protocol requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of diabetic patients having diabetic eye complications | study visit |
| Percentage of diabetic patients having dyslipidemia and hypertension | study visit |
| Percentage of diabetic patients having cardiovascular complications | study visit |
| Percentage of diabetic patients having peripheral vascular disease | study visit |
| Percentage of diabetic patients having diabetic nephropathy | study visit |
| Mean age of onset of either type 1 or type 2 diabetes mellitus | study visit |
| Mean duration of treatment of type 2 diabetes mellitus. | study visit |
| Percentage of patients on either insulin therapy or OAD (oral anti-diabetic drug) therapy. | study visit |
| Mean duration of diabetes in type 1 and type 2 diabetes patients respectively. | study visit |
| Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients. | study visit |
| Percentage of diabetic patients with HbA1c target below or equal to 7.0%. | study visit |
| Percentage of diabetic patients with HbA1c target below or equal to 6.5%. | study visit |
Secondary
| Measure | Time frame |
|---|---|
| Physician questionnaire measuring awareness about:HbA1c test and its goal, Anti-diabetic treatment and Barriers towards optimum diabetes control | study visit |
| Duration of diabetes associated with highest number of diabetic complications | study visit |
| Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy) | study visit |
| Patients' perception will be analysed through Patient questionnaire measuring:Psychological well-being, Quality of life and Patients' compliant to treatment | study visit |
Countries
Indonesia
Outcome results
None listed